{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:18:26Z","timestamp":1790957906968,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ejmech.2019.04.020","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T02:43:44Z","timestamp":1555382624000},"page":"198-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["InCl3 mediated heteroarylation of indoles and their derivatization via C H activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and\/or multiple sclerosis"],"prefix":"10.1016","volume":"174","author":[{"given":"Rajnikanth","family":"Sunke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramudu","family":"Bankala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Thirupataiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.V.V. Shivaji","family":"Ramarao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jetta Sandeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hari Maduri","family":"Doss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavender","family":"Medishetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushkar","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Kumar","family":"Kapavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahaboobkhan","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayesh","family":"Mudgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessy E.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautham G.","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore V.L.","family":"Parsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manojit","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.04.020_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","article-title":"Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling","volume":"76","author":"Conti","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2019.04.020_bib2","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1038\/sj.bjp.0706495","article-title":"Phosphodiesterase inhibitors","volume":"147","author":"Boswell-Smith","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.04.020_bib3a","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00063030-200013020-00002","article-title":"Phosphodiesterase type 4 inhibitors: potential in the treatment of multiple sclerosis?","volume":"13","author":"Dinter","year":"2000","journal-title":"BioDrugs"},{"key":"10.1016\/j.ejmech.2019.04.020_bib3b","doi-asserted-by":"crossref","first-page":"[96]","DOI":"10.1186\/1741-7015-11-96","article-title":"Phosphodiesterase 4-targeted treatments for autoimmune diseases","volume":"11","author":"Kumar","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.ejmech.2019.04.020_bib4a","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjp.2008.307","article-title":"PDE4 inhibitors: current status","volume":"155","author":"Spina","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.04.020_bib4b","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1021\/jm800582j","article-title":"Recent advances of phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease","volume":"18","author":"Kodimuthali","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.020_bib4c","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1574885511666160421145339","article-title":"Recent advances using phosphodiesterase 4 (PDE4) inhibitors to treat inflammatory disorders: animal and clinical studies","volume":"11","author":"Lin","year":"2016","journal-title":"Curr. Drug Ther."},{"key":"10.1016\/j.ejmech.2019.04.020_bib4d","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.04.020_bib5","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3899\/jrheum.140875","article-title":"GRAPPA Treatment Guideline Committee. Systematic review of treatments for psoriatic arthritis: 2014 update for the GRAPPA","volume":"41","author":"Coates","year":"2014","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.ejmech.2019.04.020_bib6","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s40265-015-0439-1","article-title":"Apremilast: a review in psoriasis and psoriatic arthritis","volume":"75","author":"Deeks","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2019.04.020_bib7a","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/COPD.S89849","article-title":"Roflumilast: a review of its use in the treatment of COPD","volume":"11","author":"Wedzicha","year":"2016","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.ejmech.2019.04.020_bib7b","series-title":"FDA Approves Eucrisa for Eczema","year":"2016"},{"key":"10.1016\/j.ejmech.2019.04.020_bib8a","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","article-title":"Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages","volume":"175","author":"Jin","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2019.04.020_bib8b","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3797\/scipharm.1404-08","article-title":"Selective phosphodiesterase 4B inhibitors: a review","volume":"82","author":"Azam","year":"2014","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejmech.2019.04.020_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI0215506","article-title":"Deletion of phosphodiesterase 4D in mice shortens a2-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis","volume":"110","author":"Robichaud","year":"2002","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.ejmech.2019.04.020_bib10a","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ejmech.2017.12.069","article-title":"Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis","volume":"145","author":"Purushothaman","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.020_bib10b","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.bmcl.2010.02.044","article-title":"Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitors","volume":"20","author":"Donnell","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.04.020_bib10c","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.bmcl.2009.04.121","article-title":"Discovery of selective PDE4B inhibitors","volume":"19","author":"Naganuma","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.04.020_bib10d","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1016\/j.bmc.2009.03.061","article-title":"Identification of PDE4B over 4D subtype-selective inhibitors revealing an unprecedented binding mode","volume":"17","author":"Kranz","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.020_bib11a","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.2174\/138161208786898653","article-title":"Subtype selectivity in phosphodiesterase 4 (PDE 4): a bottleneck in rational drug design","volume":"14","author":"Srivani","year":"2008","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.04.020_bib11b","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1021\/jm701635j","article-title":"Design, synthesis, and structure-activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors","volume":"51","author":"Zheng","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.020_bib11c","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/BJ20070970","article-title":"Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors","volume":"408","author":"Wang","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2019.04.020_bib11d","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cellsig.2013.12.003","article-title":"Structural basis for the design of selective phosphodiesterase 4b inhibitors","volume":"26","author":"Fox","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2019.04.020_bib11e","doi-asserted-by":"crossref","first-page":"7095","DOI":"10.1523\/JNEUROSCI.3212-15.2016","article-title":"Chronic cognitive dysfunction after traumatic brain injury is improved with a phosphodiesterase 4b inhibitor","volume":"36","author":"Titus","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2019.04.020_bib11f","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1016\/j.bmcl.2014.06.002","article-title":"Discovery of triazines as selective pde4b versus pde4d inhibitors","volume":"24","author":"Hagen","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.04.020_bib12","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1039\/c3ob27424a","article-title":"Novel N-indolylmethyl substituted olanzapine derivatives: their design, synthesis and evaluation as PDE4B inhibitors","volume":"11","author":"Gorja","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2019.04.020_bib13","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.bmc.2012.02.027","article-title":"C-C bond formation at C-2 of a quinolone ring: synthesis of 2-(1H-indol-3-yl)quinolone-3-carbonitrile as a new class of PDE4 inhibitors","volume":"20","author":"Kumar","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.020_bib14a","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1016\/j.tetlet.2007.04.070","article-title":"Isonitriles as efficient ligands in Suzuki-Miyaura reaction","volume":"48","author":"Villemin","year":"2007","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.04.020_bib14b","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/jhet.5570420726","article-title":"Aryl-aryl bonds formation in pyridine and diazine series","volume":"42","author":"Boully","year":"2005","journal-title":"J.\u00a0Heterocyclic Chem"},{"key":"10.1016\/j.ejmech.2019.04.020_bib14c","first-page":"2535","article-title":"Facile synthesis of 2,3-disubstituted quinoxalines by Suzuki-Miyaura coupling","author":"Mao","year":"2004","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2019.04.020_bib15","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.bmc.2012.01.012","article-title":"AlCl3 induced (hetero)arylation of 2,3-dichloroquinoxaline: a one-pot synthesis of mono\/disubstituted quinoxalines as potential antitubercular agents","volume":"20","author":"Kumar","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.020_sref7","unstructured":"For reviews, see"},{"key":"10.1016\/j.ejmech.2019.04.020_bib16a","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1016\/j.tet.2012.06.099","article-title":"Recent advances in InCl3-catalyzed one-pot organic synthesis","volume":"68","author":"Singh","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2019.04.020_bib16b","doi-asserted-by":"crossref","first-page":"[591]","DOI":"10.1002\/ejoc.200900895","article-title":"Recent developments in indium metal and its salts in organic synthesis","author":"Yadav","year":"2010","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2019.04.020_sref8","unstructured":"For selected examples, see:"},{"key":"10.1016\/j.ejmech.2019.04.020_bib17a","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jccs.201500540","article-title":"Indium trichloride (InCl3) catalyzed synthesis of fused 7\u2212Azaindole derivatives using domino knoevenagel-michael reaction","volume":"63","author":"Dongare","year":"2016","journal-title":"J.\u00a0Chin. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.04.020_bib17b","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.biortech.2014.09.077","article-title":"InCl3-catalyzed conversion of carbohydrates into 5-hydroxymethylfurfural in biphasic system","volume":"172","author":"Shen","year":"2014","journal-title":"Bioresour. Technol."},{"key":"10.1016\/j.ejmech.2019.04.020_bib17c","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1039\/c2ra00987k","article-title":"InCl3 catalyzed domino route to 2H-chromene-2-ones via [4\u00a0+ 2] annulation of 2-hydroxyarylaldehydes with \u03b1-oxoketene dithioacetal under solvent-free conditions","volume":"2","author":"Verma","year":"2012","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2019.04.020_bib17d","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1055\/s-0029-1218721","article-title":"Three-component reaction of a \u03b4-Hydroxy-\u03b1,\u03b2-Unsaturated aldehyde with arylamines and 1,3-diketones: a novel synthesis of oxa-aza bicycles","author":"Reddy","year":"2010","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2019.04.020_bib17e","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1016\/j.tetlet.2009.04.089","article-title":"InCl[3]-catalyzed efficient one-pot synthesis of 2-pyrrolo-3\u2032-yloxindoles","volume":"50","author":"Shanthi","year":"2009","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.04.020_sref9","unstructured":"For selected references, see:"},{"key":"10.1016\/j.ejmech.2019.04.020_bib18a","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0040-4039(00)90648-8","article-title":"Aromatic substitution of styrene-palladium chloride complex","volume":"8","author":"Moritani","year":"1967","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.04.020_bib18b","article-title":"Catalytic functionalization of arenes and alkanes via C-H bond activation","volume":"34","author":"Jia","year":"2001","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2019.04.020_bib18c","doi-asserted-by":"crossref","first-page":"[634]","DOI":"10.1002\/chem.201303670","article-title":"Towards ideal synthesis: alkenylation of aryl C-H bonds by a Fujiwara-Moritani reaction","volume":"20","author":"Zhou","year":"2014","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2019.04.020_bib19a","doi-asserted-by":"crossref","first-page":"13602","DOI":"10.1021\/ja5082734","article-title":"Palladium-catalyzed aryl C-H olefination with unactivated, aliphatic alkynes","volume":"136","author":"Deb","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.04.020_bib19b","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1002\/anie.200801544","article-title":"Ruthenium-catalyzed oxidative cross-coupling of chelating arenes and cycloalkanes","volume":"47","author":"Deng","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.04.020_bib19c","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1021\/ja051402f","article-title":"Oxidative C-H activation\/C-C bond forming reactions: synthetic scope and mechanistic insight","volume":"127","author":"Kalyani","year":"2005","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.04.020_bib19d","doi-asserted-by":"crossref","first-page":"14047","DOI":"10.1021\/ja065718e","article-title":"Highly regioselective catalytic oxidative coupling reactions: synthetic and mechanistic investigations","volume":"128","author":"Hull","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.04.020_bib20","doi-asserted-by":"crossref","first-page":"70604","DOI":"10.1039\/C5RA14671B","article-title":"Quinoxaline: a new directing group for ortho C-H alkenylation\/intramolecular ortho C\u2013H cycloamination under open air leading to bioactive polynuclear N-heteroarenes","volume":"5","author":"Sunke","year":"2015","journal-title":"M.\u00a0Pal, RSC Adv."},{"key":"10.1016\/j.ejmech.2019.04.020_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1006\/bbrc.1997.6636","article-title":"Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) sub-types A, B, C, and D","volume":"234","author":"Wang","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2019.04.020_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.msard.2016.11.010","article-title":"Novel zebrafish EAE model: a quick in\u00a0vivo screen for multiple sclerosis","volume":"11","author":"Kulkarni","year":"2017","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419303265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419303265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:54:10Z","timestamp":1759326850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419303265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":51,"alternative-id":["S0223523419303265"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.04.020","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"InCl3 mediated heteroarylation of indoles and their derivatization via CH activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and\/or multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}